Overview of Brazilian Requirements for Therapeutic Equivalence of Orally Inhaled and Nasal Drug Products
Crossref DOI link: https://doi.org/10.1208/s12249-019-1415-y
Published Online: 2019-06-24
Published Print: 2019-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Silva, Marcia Cavallin
Costa, Helena Silveira
Valadares, Bruna Nardy
Grecchi, Leticia
Nagao, Lee
Santos, Gustavo Mendes Lima
Text and Data Mining valid from 2019-06-24
Version of Record valid from 2019-06-24
Article History
Received: 16 February 2019
Accepted: 8 May 2019
First Online: 24 June 2019